Vaccine supply chains disrupted by U.S. restrictions: Curevac co-founder

Global supply chains for making COVID-19 vaccines have been disrupted by U.S. restrictions, creating headaches for companies seeking to build production in Europe, according to one of the founders of Germany's Curevac.